FDA Adverse Event Tracking for Pharmaceuticals

Pharmaceutical companies must diligently monitor for public discussions of adverse drug events to ensure FDA compliance. Track social media mentions to identify potential side effects, product issues, and off-label use in real-time.

Try free → See pricing

The problem

Pharmaceutical companies, such as Pfizer or Merck, operate under strict FDA regulations, requiring meticulous tracking and reporting of adverse drug events (ADEs) and product issues. Public discussions on platforms like Reddit or patient support groups on Facebook (when connected via API) can be early indicators of previously unknown side effects, off-label use, or manufacturing defects. Missing these early signals can lead to significant regulatory penalties, costly product recalls, and severe damage to patient trust and brand reputation.

Traditional pharmacovigilance relies heavily on direct patient and clinician reports, which can be slow and incomplete. Social media offers an unfiltered, real-time stream of patient experiences, but manually sifting through millions of posts for mentions of specific drug names, symptoms, and dosages is an overwhelming task. Without a systematic monitoring tool, pharma companies struggle to demonstrate comprehensive surveillance for post-market safety, leaving them vulnerable to compliance failures and delayed responses to critical public health information.

How Mentionly solves it

Monitor public social media for specific drug names, active ingredients, and keywords associated with adverse events or side effects.

Receive real-time alerts on potential adverse drug reactions or product issues, enabling rapid investigation and internal reporting.

Maintain a comprehensive, timestamped log of relevant mentions, facilitating FDA compliance reporting and risk management.

Concrete example

Detected Potential Adverse Event:
Platform: Reddit (r/medications)
Keyword Match: "DrugX" + "severe headache"
Snippet: "Started DrugX last week, now have severe headaches every day. Anyone else?"
Action: Flag for pharmacovigilance team, investigate user context, consider internal report.

Ready to try Mentionly?

Social media monitoring + engagement, in one inbox.

Get started → See pricing

Frequently asked questions

How does Mentionly assist with FDA reporting requirements for adverse events?

Mentionly helps identify potential adverse events discussed publicly, providing immediate alerts and a documented trail of these mentions, which can then be investigated and formally reported to regulatory bodies like the FDA.

Can Mentionly differentiate between general drug discussions and actual adverse event reports?

By using precise keyword combinations (drug name + symptom terms), and allowing human review, teams can effectively filter for potentially relevant adverse event discussions, minimizing false positives while ensuring critical signals are caught.

Is Mentionly able to monitor for off-label drug use discussions?

Yes, by monitoring for drug names in combination with conditions or indications not approved on the label, pharmaceutical companies can identify and track discussions related to off-label use for compliance purposes.